Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Blockbuster dreams for Pfizer's CDK inhibitor.

× No keyword cloud information.

20 in total

1. Pfizer's CDK4/6 inhibitor approved for advanced breast cancer.

Authors: Chris Morrison
Journal: Nat Biotechnol Date: 2015-04 Impact factor: 54.908

Review 2. Cellular senescence: from physiology to pathology.

Authors: Daniel Muñoz-Espín; Manuel Serrano
Journal: Nat Rev Mol Cell Biol Date: 2014-07 Impact factor: 94.444

Review 3. The other side of the coin: the tumor-suppressive aspect of oncogenes and the oncogenic aspect of tumor-suppressive genes, such as those along the CCND-CDK4/6-RB axis.

Authors: Xiaomin Lou; Ju Zhang; Siqi Liu; Ningzhi Xu; D Joshua Liao
Journal: Cell Cycle Date: 2014-05-05 Impact factor: 4.534

Review 4. Exploiting senescence for the treatment of cancer.

Authors: Liqin Wang; Lina Lankhorst; René Bernards
Journal: Nat Rev Cancer Date: 2022-03-03 Impact factor: 69.800

5. 7SK small nuclear RNA inhibits cancer cell proliferation through apoptosis induction.

Authors: Farid Keramati; Ehsan Seyedjafari; Parviz Fallah; Masoud Soleimani; Hossein Ghanbarian
Journal: Tumour Biol Date: 2014-12-10

6. The CDK4/CDK6 inhibitor PD0332991 paradoxically stabilizes activated cyclin D3-CDK4/6 complexes.

Authors: Sabine Paternot; Bianca Colleoni; Xavier Bisteau; Pierre P Roger
Journal: Cell Cycle Date: 2014 Impact factor: 4.534

7. Direct interactions with both p27 and Cdk2 regulate Spy1-mediated proliferation in vivo and in vitro.

Authors: Mohammad Al Sorkhy; Bre-Anne Fifield; Dorothy Myers; Lisa A Porter
Journal: Cell Cycle Date: 2016 Impact factor: 4.534

8. Development of highly potent and selective diaminothiazole inhibitors of cyclin-dependent kinases.

Authors: Ernst Schonbrunn; Stephane Betzi; Riazul Alam; Mathew P Martin; Andreas Becker; Huijong Han; Rawle Francis; Ramappa Chakrasali; Sudhakar Jakkaraj; Aslamuzzaman Kazi; Said M Sebti; Christopher L Cubitt; Anthony W Gebhard; Lori A Hazlehurst; Joseph S Tash; Gunda I Georg
Journal: J Med Chem Date: 2013-05-06 Impact factor: 7.446

9. Characterization of molecular and cellular functions of the cyclin-dependent kinase CDK9 using a novel specific inhibitor.

Authors: T K Albert; C Rigault; J Eickhoff; K Baumgart; C Antrecht; B Klebl; G Mittler; M Meisterernst
Journal: Br J Pharmacol Date: 2014-01 Impact factor: 8.739

Review 10. The molecular balancing act of p16(INK4a) in cancer and aging.

Authors: Kyle M LaPak; Christin E Burd
Journal: Mol Cancer Res Date: 2013-10-17 Impact factor: 5.852